State of Tennessee, Department of Treasury’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Sell
8,034
-23,135
-74% -$5.76M 0.01% 926
2025
Q4
$7.2M Buy
31,169
+15,115
+94% +$4.13M 0.02% 472
2025
Q3
$4.21M Buy
16,054
+7,804
+95% +$1.9M 0.01% 616
2025
Q2
$1.81M Sell
8,250
-24,029
-74% -$5.14M 0.01% 930
2025
Q1
$7.23M Sell
32,279
-4,059
-11% -$1.12M 0.03% 426
2024
Q4
$11.9M Sell
36,338
-6,784
-16% -$2.13M 0.04% 326
2024
Q3
$12.9M Buy
43,122
+14,621
+51% +$4.48M 0.05% 320
2024
Q2
$9.39M Sell
28,501
-15,702
-36% -$5.55M 0.03% 384
2024
Q1
$17.5M Buy
44,203
+6,757
+18% +$2.5M 0.06% 260
2023
Q4
$13.2M Buy
37,446
+18,929
+102% +$6.7M 0.05% 309
2023
Q3
$6.95M Sell
18,517
-1,017
-5% -$393K 0.03% 440
2023
Q2
$7.47M Buy
19,534
+8,131
+71% +$2.9M 0.03% 377
2023
Q1
$3.95M Buy
11,403
+374
+3% +$109K 0.02% 553
2022
Q4
$2.6M Sell
11,029
-877
-7% -$208K 0.01% 736
2022
Q3
$2.93M Hold
11,906
0.01% 658
2022
Q2
$3.6M Hold
11,906
0.02% 581
2022
Q1
$4.89M Sell
11,906
-14,586
-55% -$5.71M 0.02% 546
2021
Q4
$12.4M Buy
26,492
+4,386
+20% +$1.89M 0.05% 306
2021
Q3
$9.39M Buy
22,106
+2,976
+16% +$1.25M 0.04% 332
2021
Q2
$6.87M Buy
19,130
+5,954
+45% +$1.97M 0.03% 443
2021
Q1
$3.71M Sell
13,176
-92
-0.7% -$26.3K 0.02% 655
2020
Q4
$3.76M Sell
13,268
-9,879
-43% -$2.77M 0.02% 600
2020
Q3
$6.36M Buy
23,147
+8,014
+53% +$2.12M 0.03% 399
2020
Q2
$3.44M Sell
15,133
-40,811
-73% -$8.02M 0.02% 550
2020
Q1
$8.52M Buy
55,944
+5,232
+10% +$805K 0.05% 281
2019
Q4
$7.62M Sell
50,712
-18,360
-27% -$2.67M 0.03% 385
2019
Q3
$9.8M Buy
69,072
+50,800
+278% +$6.99M 0.05% 329
2019
Q2
$2.29M Sell
18,272
-1,659
-8% -$196K 0.01% 756
2019
Q1
$2.2M Hold
19,931
0.01% 778
2018
Q4
$1.95M Buy
19,931
+396
+2% +$43K 0.01% 779
2018
Q3
$2.41M Sell
19,535
-465
-2% -$52.1K 0.01% 767
2018
Q2
$1.99M Sell
20,000
-20,000
-50% -$1.84M 0.01% 820
2018
Q1
$3.53M Hold
40,000
0.02% 637
2017
Q4
$3.95M Sell
40,000
-40,000
-50% -$3.92M 0.02% 635
2017
Q3
$7.7M Hold
80,000
0.04% 409
2017
Q2
$7.56M Buy
80,000
+50,000
+167% +$4.6M 0.04% 432
2017
Q1
$2.45M Sell
30,000
-20,000
-40% -$1.67M 0.01% 789
2016
Q4
$4.24M Sell
50,000
-70,000
-58% -$5.5M 0.02% 581
2016
Q3
$8.94M Buy
120,000
+100,000
+500% +$7.94M 0.04% 388
2016
Q2
$1.52M Hold
20,000
0.01% 848
2016
Q1
$1.39M Buy
+20,000
New +$1.2M 0.01% 846
2015
Q3
Sell
-55,500
Closed -$3.22M 1229
2015
Q2
$3.22M Buy
55,500
+300
+0.5% +$16.7K 0.02% 604
2015
Q1
$3.32M Hold
55,200
0.02% 642
2014
Q4
$2.94M Sell
55,200
-5,500
-9% -$275K 0.02% 621
2014
Q3
$2.72M Hold
60,700
0.02% 607
2014
Q2
$2.56M Sell
60,700
-2,300
-4% -$98.5K 0.01% 627
2014
Q1
$2.77M Sell
63,000
-10,000
-14% -$471K 0.02% 609
2013
Q4
$3.58M Hold
73,000
0.02% 600
2013
Q3
$3M Buy
+73,000
New +$2.78M 0.02% 645

Other funds holding WST

State of Tennessee, Department of Treasury's WST Position: Q1 2026 in Review

State of Tennessee, Department of Treasury reduced its West Pharmaceutical (WST) stake by 74% in Q1 2026, selling an estimated $5.76M and leaving 8,034 shares worth $2.01M. The position accounts for 0.01% of the portfolio, ranked #926.

State of Tennessee, Department of Treasury first reported a position in WST in Q3 2013 and has held it in 49 quarters since. The position peaked at $17.5M in Q1 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • State of Tennessee, Department of Treasury held 8,034 shares of West Pharmaceutical worth $2.01M as of Q1 2026.
  • State of Tennessee, Department of Treasury sold 23,135 West Pharmaceutical shares in Q1 2026, an estimated $5.76M.
  • West Pharmaceutical made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #926 holding.
  • State of Tennessee, Department of Treasury first reported a position in West Pharmaceutical in Q3 2013 and has held it in 49 quarters since.
  • State of Tennessee, Department of Treasury's West Pharmaceutical position peaked at $17.5M in Q1 2024.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.